Treatment of Oral Thrush (Candidiasis)

First-line Treatment Options

• The Infectious Diseases Society of America recommends oral fluconazole 100-200 mg daily for 7-14 days as the most effective treatment for moderate to severe oral thrush 1, 2
• For mild oral thrush, clotrimazole troches (10 mg 5 times daily for 7-14 days) are recommended 3
• Nystatin suspension (100,000 U/mL, 4-6 mL four times daily) or pastilles (200,000 U, 1-2 pastilles 4-5 times daily) for 7-14 days are also recommended for mild oral thrush 3

Treatment for Fluconazole-Refractory Cases

• Itraconazole oral solution 200 mg daily for 7-14 days (64-80% response rate) is recommended for fluconazole-refractory cases 1, 2
• Voriconazole 200 mg twice daily (oral or IV) for 14-21 days is recommended for fluconazole-refractory cases 1, 2
• Posaconazole suspension 400 mg twice daily (approximately 75% efficacy in refractory cases) is recommended for fluconazole-refractory cases 1, 2

Alternative Therapies for Refractory Cases

• Echinocandins, such as micafungin (150 mg daily), caspofungin (70-mg loading dose, then 50 mg daily), and anidulafungin (200 mg daily), are recommended for severe refractory cases 1, 2
• Amphotericin B deoxycholate 0.3-0.7 mg/kg daily is a less preferred alternative for refractory cases 1, 2

Special Considerations

• The Infectious Diseases Society of America recommends proper denture hygiene and disinfection of dentures in addition to antifungal therapy for definitive cure of denture-related thrush 3
• Antiretroviral therapy should be used whenever possible to reduce recurrent infections in HIV-infected patients 1, 2
• For recurrent infections in HIV patients, suppressive therapy with fluconazole 100-200 mg three times weekly is recommended 1, 2

Important Clinical Pitfalls

• Treatment should be continued for the full recommended duration even if symptoms resolve quickly 1, 2

Treatment of Oral Thrush (Candidiasis)

Treatment Algorithm Based on Severity

• For mild oral thrush, the Infectious Diseases Society of America recommends clotrimazole troches, 10 mg 5 times daily for 7-14 days, or miconazole mucoadhesive buccal 50-mg tablet applied to the mucosal surface over the canine fossa once daily for 7-14 days 4, 5
• For moderate to severe oral thrush, the Infectious Diseases Society of America strongly recommends oral fluconazole, 100-200 mg daily for 7-14 days, with high-quality evidence 4, 5, 6

Special Considerations

• For denture-related candidiasis, proper denture hygiene is essential for cure, and disinfection of the denture in addition to antifungal therapy is recommended 4, 5, 7
• For HIV-infected patients, antiretroviral therapy is strongly recommended to reduce recurrent infections, and these patients may require more aggressive initial therapy 4, 5, 8
• For patients with frequent recurrences, suppressive therapy with fluconazole 100 mg three times weekly is recommended 4, 9

Potential Pitfalls and Caveats

• Azole-refractory infections are more common in patients with prior azole use and severely immunocompromised patients 8, 9
• Oropharyngeal fungal cultures are of little benefit as many individuals have asymptomatic colonization, and treatment frequently does not result in microbiological cure 9, 10
• For patients unable to tolerate oral medications, parenteral therapy should be used 10

Oral Candidiasis: Diagnosis and Management

Clinical Appearance

• Denture‑related candidiasis typically presents as diffuse erythema beneath denture‑bearing areas of the oral mucosa. 11

Treatment of Mild Disease

• First‑line therapy for mild oral thrush is topical clotrimazole troches (10 mg) administered five times daily for 7–14 days. 11
• An alternative topical option is a miconazole mucoadhesive buccal tablet (50 mg) applied once daily to the mucosal surface for 7–14 days. 11
• Second‑line topical agents include nystatin suspension (100,000 U/mL) 4–6 mL four times daily or nystatin pastilles (200,000 U each) 1–2 pastilles four times daily for 7–14 days. 11

Treatment of Moderate to Severe Disease

• Oral fluconazole (100–200 mg daily) for 7–14 days is the recommended first‑line systemic therapy for moderate to severe oral candidiasis. The recommendation is supported by strong evidence. 11

Management of Fluconazole‑Refractory Disease

• If clinical response is inadequate after 7–14 days of fluconazole, switch to itraconazole oral solution (200 mg once daily) or posaconazole suspension (400 mg twice daily for 3 days, then 400 mg daily) for up to 28 days. 11
• Alternative oral agents include voriconazole (200 mg twice daily) or amphotericin B deoxycholate suspension (100 mg/mL) four times daily. 11
• For severe refractory cases requiring parenteral therapy, use an intravenous echinocandin:
  
  • Caspofungin 70 mg loading dose then 50 mg daily, or
  • Micafungin 100 mg daily, or
  • Anidulafungin 200 mg loading dose then 100 mg daily. 11

Special Clinical Situations

Denture‑Related Candidiasis

• In addition to antifungal agents, mandatory disinfection of dentures is required to achieve definitive cure. 11

HIV‑Infected Patients

• Initiating or optimizing antiretroviral therapy is the most important intervention to reduce recurrent oral candidiasis. 11
• For patients with recurrent infection despite antiretroviral therapy, chronic suppressive fluconazole (100 mg three times weekly) is recommended. 11
• Individuals with markedly low immune cell counts (e.g., CD4 < 200 cells/µL) are at the highest risk for oral candidiasis. 11